Table: Kringle Pharma - 6-MTH parent results

Kringle Pharma

15/05/2023 07:40

May 15 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Mar 31, 2023        Mar 31, 2022       Sep 30, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            34 mln              27 mln             68 mln     
                 (+25.8 pct)         (-76.8 pct)       (-82.4 pct)   
  Operating     loss 314 mln        loss 310 mln       loss 993 mln  
  Recurring     loss 314 mln        loss 318 mln       loss 953 mln  
  Net           loss 315 mln        loss 319 mln       loss 955 mln  
  EPS          loss 58.63 yen      loss 70.24 yen    loss 177.44 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                                             
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T